Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing ...

Axcend and MassTech, Inc. announced that Axcend will offer the MassTech MTE30 as part of a combined liquid ...

Emerging from stealth, RecovryAI introduces AI-powered, physician-prescribed Virtual Care Assistants for post-operative recoverySAN FRANCISCO--(BUSINESS WIRE)--RecovryAI today announced that the U.S.

Seasoned biopharma executive brings more than 25 years of business development and strategic partnership experience to ...

The Global Point-of-Care (POC) Diagnostics Market is projected to expand at a CAGR of 11% through 2028. Growth is being fueled by the rising burden of infectious diseases, increasing demand for rapid ...

Point-of-care testing refers to diagnostic procedures conducted near the patient or at the site of care, outside of ...

Global Heparin Market OverviewThe Global Heparin Market is projected to grow steadily at a CAGR of approximately 5% by 2026.

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast period. This rapid expansion is primarily fueled by the rising prevalence of ...

The global weight management market is projected to grow at a rate of 9-10% by 2029. This expansion is driven by several key ...

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional gut lymphatics and local inflammation linked to metabolic disease and ...

Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Jonathan M. Poole to its Board of Directors, effective March 3, 2026. Mr. Poole will serve on the Company’s Audit ...